Homepage
Medication Guide
What Are the Side Effects of Pramipexole?
Pramipexole is a non-ergot dopamine agonist used for the treatment of Parkinson's Disease and moderate-to-severe primary Restless Legs Syndrome (RLS). As a dopamine receptor agonist, while it impr...
501
Friday, October 24th, 2025, 10:43
Precautions for Pramipexole Administration
Pramipexole is a non-ergot dopamine receptor agonist used for the treatment of Parkinson's Disease (PD) and moderate-to-severe primary Restless Legs Syndrome (RLS). Its efficacy and safety are hig...
502
Friday, October 24th, 2025, 10:38
Indications for Indications for Pramipexole
Pramipexole is a non-ergot dopamine receptor agonist, primarily indicated for the treatment of Parkinson's Disease (PD) and moderate-to-severe primary Restless Legs Syndrome (RLS).Indications for ...
504
Friday, October 24th, 2025, 10:29
What Are the Side Effects of Eliglustat (Cerdelga)?
Eliglustat (Cerdelga) is a glucosylceramide synthase inhibitor used for the long-term treatment of Type 1 Gaucher Disease in adults, with eliglustat as its active ingredient.What Are the Side Effects ...
502
Friday, October 24th, 2025, 09:27
Precautions for Eliglustat (Cerdelga) Administration
Eliglustat (Cerdelga) is a glucosylceramide synthase inhibitor indicated for the long-term treatment of Type 1 Gaucher Disease (GD1) in adults. Its efficacy and safety are highly dependent on individu...
502
Friday, October 24th, 2025, 09:23
Indications for Eliglustat (Cerdelga)
Eliglustat (Cerdelga) is an oral medication used for the treatment of Type 1 Gaucher Disease (GD1). It alleviates the symptoms of Gaucher Disease by reducing the production of glucosylceramide (GL-1)....
502
Friday, October 24th, 2025, 09:18
How to Purchase Cerdelga (Elglustat)
Cerdelga (Elglustat) is a prescription medication used for the treatment of adult patients with Type 1 Gaucher disease. Classified as a glucosylceramide synthase inhibitor, it has specific indications...
502
Thursday, October 23rd, 2025, 11:54
How to Purchase Sacituzumab Govitecan-hziy (Elahere)
Sacituzumab govitecan-hziy (Elahere) is an antibody-drug conjugate (ADC) targeting folate receptor alpha (FRα), indicated for the treatment of FRα-positive, platinum-resistant epithelial ovarian, fall...
501
Thursday, October 23rd, 2025, 11:48
Indications of Revumenib (Revuforj)
Revumenib (Revuforj) is a novel menin inhibitor developed by Syndax Pharmaceuticals. It was first approved in the United States in 2024.Indications of Revumenib (Revuforj)Relapsed or Refractory Acute ...
501
Thursday, October 23rd, 2025, 11:33
How to Use Sacituzumab Govitecan-hziy (Elahere)
Sacituzumab govitecan-hziy (Elahere) is an antibody-drug conjugate (ADC) targeting folate receptor alpha (FRα). It was approved by the U.S. FDA in 2022 for the treatment of adult patients with FRα-pos...
501
Thursday, October 23rd, 2025, 11:22
10 / 137
1369 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved